Seeking Alpha

Edwards Lifesciences (EW +5.4%) shares surge to the top of the S&P after a study shows...

Edwards Lifesciences (EW +5.4%) shares surge to the top of the S&P after a study shows elderly patients receiving its Sapien heart valve implanted through the ribs as part of an expanded access program reaped more benefit than those observed in initial trials. Cannacord, which rates shares a Buy, thinks the data will ease FDA concerns, and raises its target price to $95 from $90.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs